Inventor

DROPULIC BORO

US50 patents

⚠️ This page may combine multiple inventors who share the name “DROPULIC BORO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DROPULIC BORO

LENTIGEN TECH INC

Compositions and methods for treating cancer with anti-CD123 immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with anti-CD33 immunotherapy

Compositions and methods for treating cancer with anti-CD38 immunotherapy

Method to treat cancer with engineered T-cells

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Compositions and methods for treating cancer with DuoCARs

Compositions and methods for treating cancer with DuoCARs

Compositions and methods for treating cancer with anti-BCMA immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with DuoCARs

Compositions and methods for treating cancer with DuoCARs

Compositions and methods for treating HIV/AIDS with immunotherapy

Compositions and methods for treating cancer with anti-ROR1 immunotherapy

Compositions and methods for treating cancer with anti-CD38 immunotherapy

Compositions and methods for treating cancer with DuoCARs

Compositions and methods for treating cancer with anti-CD123 immunotherapy

Compositions and methods for treating cancer with anti-mesothelin immunotherapy

Chimeric antigen receptors and methods of use

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

Compositions and methods for treating cancer with anti-CD33 immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Method to treat cancer with engineered T-cells

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Compositions and methods for treating HIV/AIDS with immunotherapy

Compositions and methods for treating cancer with anti-BCMA immunotherapy

Compositions and methods for treating cancer with self-driving chimeric antigen receptors

Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy

UNIV JOHNS HOPKINS MED

Methods to inhibit replication of infective virus

Method of using a conditionally replicating viral vector to express a gene

Genetic antiviral agents and methods for their use

Methods to prepare conditionally replicating viral vectors

Lentiviral vectors

Methods to express genes from viral vectors

Methods to assay gene function with viral vectors

Viral vectors and host cells and methods of making and using them

Conditionally replicating viral vectors and their use

VIRXSYS CORP

Methods for stable transduction of cells with hiv-derived viral vectors

Regulated nucleic acid expression system

Regulated nucleic acid expression system

High-throughput methods for identifying gene function using lentiviral vectors

LENTIGENTECHNOLOGY INC

Compositions and methods for treating cancer with anti-CD22 immunotherapy

Compositions and methods for treating cancer with anti-CD19/CD22 immunotherapy

Compositions and methods for treating cancer with anti-CD22 immunotherapy

MILTENYI BIOTEC TECH INC

Chimeric antigen receptors and methods of use